NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial
Titel:
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial
Auteur:
Gregorc, Vanesa Gaafar, Rabab M Favaretto, Adolfo Grossi, Francesco Jassem, Jacek Polychronis, Andreas Bidoli, Paolo Tiseo, Marcello Shah, Riyaz Taylor, Paul Novello, Silvia Muzio, Alberto Bearz, Alessandra Greillier, Laurent Fontana, Floriana Salini, Giulia Lambiase, Antonio O'Brien, Mary